Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Kessler, R. C. Articles by Berglund, P. Search for Related Content PubMed Citation Articles by Kessler, R. C. Articles by Berglund, P.

Social Phobia Subtypes in the National Comorbidity Survey

OBJECTIVE: This article presents epidemiologic data on the distinction between social phobia characterized by pure speaking fears and that characterized by other social fears. METHOD: The data come from the National Comorbidity Survey (N=8,098). Social phobia was assessed with a revised version of the Composite International Diagnostic Interview. RESULTS: Latent class analysis showed that the brief set of social fears assessed in the survey can be disaggregated into a class characterized largely by speaking fears and a second class characterized by a broader range of social fears. One-third of the people with lifetime social phobia exclusively reported speaking fears, while the other two-thirds also had at least one of the other social fears assessed. The vast majority of the latter had multiple social fears including, in most cases, both performance and interactional fears. The two subtypes were similar in age at onset distribution, family history, and certain sociodemographic correlates. However, the social phobia characterized by pure speaking fears was less persistent, less impairing, and less highly comorbid with other DSM-III-R disorders than was social phobia characterized by other social fears. CONCLUSIONS: Further general population research assessing more performance and interaction fears is needed to determine whether social phobia subtypes can be refined and whether the subtypes are better conceptualized as distinct disorders. In the meantime, people who have social phobia with multiple fears, some of which are nonspeaking fears, appear to have the most impairment and should be the main focus of prevention and intervention efforts.

This article has been cited by other articles:

				J. Cairney, L. McCabe, S. Veldhuizen, L. M. Corna, D. Streiner, and N. Herrmann Epidemiology of Social Phobia in Later Life Am J Geriatr Psychiatry, March 1, 2007; 15(3): 224 - 233. [Abstract] [Full Text] [PDF]

				F. R. Schneier Clinical practice. Social anxiety disorder. N. Engl. J. Med., September 7, 2006; 355(10): 1029 - 1036. [Full Text] [PDF]

				S. Bellini The Development of Social Anxiety in Adolescents With Autism Spectrum Disorders Focus on Autism and Other Developmental Disabilities, January 1, 2006; 21(3): 138 - 145. [Abstract] [PDF]

				D. S. Baldwin, I. M. Anderson, D. J. Nutt, B. Bandelow, A. Bond, J. R. T. Davidson, J. A. den Boer, N. A. Fineberg, M. Knapp, J. Scott, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology J Psychopharmacol, November 1, 2005; 19(6): 567 - 596. [Abstract] [PDF]

				M. R. Liebowitz, A. J. Gelenberg, and D. Munjack Venlafaxine Extended Release vs Placebo and Paroxetine in Social Anxiety Disorder Arch Gen Psychiatry, February 1, 2005; 62(2): 190 - 198. [Abstract] [Full Text] [PDF]

				J. R. T. Davidson, E. B. Foa, J. D. Huppert, F. J. Keefe, M. E. Franklin, J. S. Compton, N. Zhao, K. M. Connor, T. R. Lynch, and K. M. Gadde Fluoxetine, Comprehensive Cognitive Behavioral Therapy, and Placebo in Generalized Social Phobia Arch Gen Psychiatry, October 1, 2004; 61(10): 1005 - 1013. [Abstract] [Full Text] [PDF]

				J. Davidson, T. Pearlstein, P. Londborg, K. T. Brady, B. Rothbaum, J. Bell, R. Maddock, M. T. Hegel, and G. Farfel Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder: Results of a 28-Week Double-Blind, Placebo-Controlled Study Focus, July 1, 2003; 1(3): 273 - 281. [Abstract] [Full Text] [PDF]

				J. Davidson, T. Pearlstein, P. Londborg, K. T. Brady, B. Rothbaum, J. Bell, R. Maddock, M. T. Hegel, and G. Farfel Efficacy of Sertraline in Preventing Relapse of Posttraumatic Stress Disorder: Results of a 28-Week Double-Blind, Placebo-Controlled Study Am J Psychiatry, December 1, 2001; 158(12): 1974 - 1981. [Abstract] [Full Text] [PDF]

				D. J. Katzelnick, K. A. Kobak, T. DeLeire, H. J. Henk, J. H. Greist, J. R.T. Davidson, F. R. Schneier, M. B. Stein, and C. P. Helstad Impact of Generalized Social Anxiety Disorder in Managed Care Am J Psychiatry, December 1, 2001; 158(12): 1999 - 2007. [Abstract] [Full Text] [PDF]

				R. M. Crum and L. A. Pratt Risk of Heavy Drinking and Alcohol Use Disorders in Social Phobia: A Prospective Analysis Am J Psychiatry, October 1, 2001; 158(10): 1693 - 1700. [Abstract] [Full Text] [PDF]

				M. B. Stein, J. Sareen, S. Hami, and J. Chao Pindolol Potentiation of Paroxetine for Generalized Social Phobia: A Double-Blind, Placebo-Controlled, Crossover Study Am J Psychiatry, October 1, 2001; 158(10): 1725 - 1727. [Abstract] [Full Text] [PDF]

				P. Grossman, F. H. Wilhelm, I. Kawachi, and D. Sparrow Gender Differences in Psychophysiological Responses to Speech Stress Among Older Social Phobics:: Congruence and Incongruence Between Self-Evaluative and Cardiovascular Reactions Psychosom Med, September 1, 2001; 63(5): 765 - 777. [Abstract] [Full Text] [PDF]

				K. A. Yonkers, I. R. Dyck, and M. B. Keller An Eight-Year Longitudinal Comparison of Clinical Course and Characteristics of Social Phobia Among Men and Women Psychiatr Serv, May 1, 2001; 52(5): 637 - 643. [Abstract] [Full Text] [PDF]

				M. B. Stein, L. J. Torgrud, and J. R. Walker Social Phobia Symptoms, Subtypes, and Severity: Findings From a Community Survey Arch Gen Psychiatry, November 1, 2000; 57(11): 1046 - 1052. [Abstract] [Full Text] [PDF]

				M. B. Stein and Y. M. Kean Disability and Quality of Life in Social Phobia: Epidemiologic Findings Am J Psychiatry, October 1, 2000; 157(10): 1606 - 1613. [Abstract] [Full Text]

				R. Lieb, H.-U. Wittchen, M. Hofler, M. Fuetsch, M. B. Stein, and K. R. Merikangas Parental Psychopathology, Parenting Styles, and the Risk of Social Phobia in Offspring: A Prospective-Longitudinal Community Study Arch Gen Psychiatry, September 1, 2000; 57(9): 859 - 866. [Abstract] [Full Text] [PDF]

				M. V. Mendlowicz and M. B. Stein Quality of Life in Individuals With Anxiety Disorders Am J Psychiatry, May 1, 2000; 157(5): 669 - 682. [Abstract] [Full Text]

				M. B. Stein, A. J. Fyer, J. R.T. Davidson, M. H. Pollack, and B. Wiita Fluvoxamine Treatment of Social Phobia (Social Anxiety Disorder): A Double-Blind, Placebo-Controlled Study Am J Psychiatry, May 1, 1999; 156(5): 756 - 760. [Abstract] [Full Text]

				M. B. Stein, M. R. Liebowitz, R. B. Lydiard, C. D. Pitts, W. Bushnell, and I. Gergel Paroxetine Treatment of Generalized Social Phobia (Social Anxiety Disorder): A Randomized Controlled Trial JAMA, August 26, 1998; 280(8): 708 - 713. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1998 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us